Zoekresultaten - 12 results

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given ...

Hepatitis C virus prevalence in Belgium

Publication Type: Peer reviewed scientific article Authors: L Van Baelen; Johan Van der Heyden Source: Experimental Results, Volume 2 (2021) Keywords: Belgium cross-sectional study Hepatitis ...

Hepatitis C virus prevalence in Belgium

Publication Type: Peer reviewed scientific article Authors: L Van Baelen; Johan Van der Heyden Source: Experimental Results, Volume 2 (2021) Keywords: Belgium cross-sectional study Hepatitis ...

Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.

only should not be used in Cambodia. Regional/national guidelines should be explicit about this. TRIAL REGISTRATION: This study was performed as part of a larger cross-sectional study on the burden of ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

from 1993 to 1994. In this first Belgian nationwide HCV prevalence study, we set out to update the seroprevalence and prevalence of chronic HCV infection estimates in the Belgian general population in ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

genotypes and subtypes in a country is crucial to guide antiviral therapy and to understand local epidemiology. Studies investigating circulating HCV genotypes and their trends have been conducted in Belgium. ...

Hepatitis E virus serology and PCR: does the methodology matter?

emerging pathogen in the developed world. As the clinical manifestations and routine laboratory parameters are often nonspecific, accurate diagnostic tests are crucial. In the current study, the performance ...

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

summary, mAb A6 is an important tool to study the structure and function of E1 within the viral envelope, a crucial step in the development of an effective prophylactic HCV  vaccine. Health Topics:  ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

Keywords: Belgium cross-sectional studies Hepacivirus Hepatitis C Humans Mass Screening Substance Abuse, Intravenous Abstract: BACKGROUND: Hepatitis C prevalence figures for people who use drugs in Belgium ...

Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method

obtained pseudo-anonymized identifier information from treatment and harm reduction service providers and a fieldwork study between February and April 2019 in Brussels. We estimated the number of PWID, ...

QR code

QR code for this page URL